These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 3260381

  • 1. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE, Vasil'ev AV, Sakharova IIa, Machkova NA, Ivanova LA.
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract] [Full Text] [Related]

  • 2. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA.
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [Abstract] [Full Text] [Related]

  • 3. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK, Korotkiĭ NG, Udzhukhu VIu, Arion VIa, Eletskiĭ AIu.
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract] [Full Text] [Related]

  • 4. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
    Sakhelashvili-Haladzhun MI.
    Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
    [Abstract] [Full Text] [Related]

  • 5. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
    Demidov SV, Miasnikov VG, Chernushenko EF, Osipova LS.
    Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].
    Demidov SV, Miasnikov VG, Chernushenko EF, Osipova LS.
    Probl Tuberk; 1991 May; (12):52-4. PubMed ID: 1803376
    [Abstract] [Full Text] [Related]

  • 7. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM, Peresadin NA, Pustovoĭ IuG, Gaĭdash IS, Tishchenko NA, Gavrilova LA, Pinskiĭ LL.
    Sov Med; 1990 May; (6):111-3. PubMed ID: 2144365
    [No Abstract] [Full Text] [Related]

  • 8. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA, Gergert VIa, Iakovleva OB.
    Probl Tuberk; 1997 May; (6):59-60. PubMed ID: 9503939
    [Abstract] [Full Text] [Related]

  • 9. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Mel'nik VP.
    Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
    [Abstract] [Full Text] [Related]

  • 10. [The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
    Skvortsova RG, Nikitina OI.
    Probl Tuberk; 1990 Apr; (5):11-4. PubMed ID: 2388887
    [Abstract] [Full Text] [Related]

  • 11. [T-activin in the complex treatment of patients with pulmonary tuberculosis].
    Ivanova LA, Pavlova MV.
    Probl Tuberk; 1986 Apr; (5):37-40. PubMed ID: 3488548
    [No Abstract] [Full Text] [Related]

  • 12. [Immunotherapy of pulmonary tuberculosis].
    Khudzik LB, Salina TIu, Parolina LE.
    Probl Tuberk; 1998 Apr; (6):23-6. PubMed ID: 10067345
    [Abstract] [Full Text] [Related]

  • 13. [Effect of thymus gland preparations on T- and B-lymphocytes in experimental tuberculosis].
    Kononko IV.
    Probl Tuberk; 1986 Apr; (2):55-8. PubMed ID: 3486412
    [No Abstract] [Full Text] [Related]

  • 14. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
    Chukanov VI, Gergert VIa, Khomenko IS.
    Probl Tuberk; 1989 Apr; (6):30-3. PubMed ID: 2771908
    [Abstract] [Full Text] [Related]

  • 15. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB, Gripas' IA, Nasibullina GKh, Belousova MA.
    Vestn Oftalmol; 1991 Apr; 107(5):51-4. PubMed ID: 1763455
    [Abstract] [Full Text] [Related]

  • 16. [Tactivin in combined treatment of patients with pulmonary tuberculosis associated with gastrointestinal diseases].
    Zhukova EM.
    Probl Tuberk; 1995 Apr; (3):25-7. PubMed ID: 7617628
    [Abstract] [Full Text] [Related]

  • 17. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI, Arion VIa, Petunina NA.
    Sov Med; 1987 Apr; (12):32-5. PubMed ID: 3502197
    [No Abstract] [Full Text] [Related]

  • 18. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA, Kamenev VF, Kolomiets VM.
    Probl Tuberk Bolezn Legk; 2007 Apr; (9):30-3. PubMed ID: 18038603
    [Abstract] [Full Text] [Related]

  • 19. [The effect of tuberculin therapy on immunologic indicators in adolescents with pulmonary tuberculosis].
    Knoring BE, Pavlova MV, Ivanova LA.
    Probl Tuberk; 1991 Apr; (12):31-4. PubMed ID: 1803370
    [Abstract] [Full Text] [Related]

  • 20. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
    Adambekov DA, Litvinov VI, Mambetov KB, Koshmuratov AG, Sabyrbekova TS.
    Probl Tuberk; 1998 Apr; (5):46-8. PubMed ID: 9866400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.